Viridian Therapeutics, Inc. (VRDN) — Analyst estimates
Consensus analyst estimates for Viridian Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 29.79M | -0.89 | 3 |
| 2027 | 121.64M | -0.28 | 2 |
| 2028 | 579.88M | -0.19 | 10 |
| 2029 | 856.62M | 1.62 | 4 |
| 2030 | 1.13B | 3.04 | 4 |
Consensus analyst estimates by fiscal year.